课题基金 / 基金详情

项目摘要

项目成果

Hannah Marion Burgess的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 环状(CIRC)RNA是最近描述的一类通过相邻外显子的反向剪接产生的RNA, 它们的表达在几种疾病状态和少数几种病毒感染中都会发生变化 已经研究过了。在功能上,CircRNAs很少指导蛋白质的合成,但与隔离有关 MicroRNAs和RNA结合蛋白(RNA-Bps)。CircRNAs最近被认为与控制 通过提供丰富的抑制库激活双链(DS)核糖核酸激活的eIF2α激酶PKR 短双链RNA序列。如果核糖核酸酶L被激活,结合的失活PKR可以被快速动员, 导致CircRNA的内切核糖核酸裂解。由RNA病毒复制和dsDNA生成 病毒从相反的基因组链转录而来,dsrna是一种有效的病原体相关分子模式。 (PAMP),其被PKR和OAS/RNA酶L途径识别导致突然防御性关闭 信使核糖核酸翻译以阻止病毒蛋白质的合成。除了可能病毒和CircRNA特异性之外 因此,CircRNA对校准dsRNA反应的潜力表明,对 病毒生物学。然而,感染细胞CircRNA群体对1型单纯疱疹病毒的确切反应 单纯疱疹病毒1型(HSV1)感染和影响病毒复制的情况仍不清楚,这是一项重大的知识差距。 这项提案的总体目标是了解CircRNA如何促进HSV1感染和 抗病毒免疫。我们在HSV1感染细胞中的初步数据表明,CircRNA受到保护 由病毒内切核酸酶VHS降解,实际上是通过一种机制选择性上调的 依赖于病毒即刻早期蛋白ICP27。我们还发现,PKR的激活依赖于 核糖核酸酶L功能,提示CircRNAs是HSV1感染中PKR的重要抑制物,必须 被降解为完全的抗病毒反应。这些数据与新的假设一致,即单纯疱疹病毒1型 操纵这类宿主RNA以逃避细胞固有的抗病毒防御并保护蛋白质合成 和病毒复制。这项建议将分为两个目的,以充分了解1)HSV1如何塑造 感染细胞循环RNA组和2)这些改变对功能的影响。这些研究将揭示如何 由HSV1操纵的CircRNA及其在感染和免疫一种医学上重要的疾病中的重要性 人类病原体。最终,这项工作可能会带来治疗多种病毒感染的新策略。 对我们理解感染、宿主防御和CircRNA生物学具有重要意义。
英文摘要
Project Summary Circular (circ) RNAs are a recently described class of RNAs generated by backsplicing of adjacent exons, whose expression is altered in several disease states and some of the few viral infections in which they have been studied. Functionally, circRNAs rarely direct protein synthesis but have been linked to the sequestration of microRNAs and RNA binding proteins (RNA-BPs). CircRNAs were recently implicated in controlling the activation of double-stranded (ds) RNA-activated eIF2α kinase PKR by providing an abundant pool of inhibitory short duplex RNA sequences. Bound inactive PKR can be rapidly mobilized by if RNase L is activated, resulting in endoribonucleolytic cleavage of circRNAs. Generated by both RNA virus replication and dsDNA virus transcription from opposing genome strands, dsRNA is a potent pathogen associated molecular pattern (PAMP) whose recognition by PKR and the OAS/RNase L pathway leads to an abrupt defensive shutdown of mRNA translation to thwart viral protein synthesis. In addition to possible virus and circRNA -specific interactions, the potential of circRNAs to calibrate dsRNA responses therefore suggests a broad significance to virus biology. However, precisely how the infected cell circRNA population responds to herpes simplex type 1 (HSV1) infection and impacts virus reproduction remains unknown and represents a significant knowledge gap. The overall goal of this proposal is to understand how circRNAs contribute to HSV1 infection and antiviral immunity. Our preliminary data in HSV1-infected cells indicate that circRNAs are protected from degradation by the viral endoribonuclease vhs and are in fact selectively upregulated through a mechanism dependent on the viral immediate early protein ICP27. We also find that PKR activation is dependent on RNase L function, suggesting that circRNAs are important inhibitors of PKR in HSV1 infection that must be degraded for a full antiviral response. These data are consistent with the novel hypothesis that HSV1 actively manipulates this class of host RNAs to evade cell intrinsic antiviral defenses and preserve protein synthesis and viral replication. This proposal will be divided into two aims to fully understand 1) how HSV1 shapes the infected cell circRNAome and 2) the functional impact of these alterations. These studies will reveal how circRNAs are manipulated by HSV1 and their importance in infection and immunity to a medically important human pathogen. Ultimately, this work could lead to new strategies for treating a wide variety of viral infections and have significant implications for our understanding of infection, host defenses and circRNA biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circular RNAs in HSV1 infection and antiviral immunity
  • 批准号:
    10495211
  • 项目类别:
  • 资助金额:
    $6.73万
  • 财政年份:
    2021
  • 负责人:
    Hannah Marion Burgess
  • 依托单位:
Cellular RNAs in anti-viral immunity to HSV1
  • 批准号:
    10553861
  • 项目类别:
  • 资助金额:
    $10.55万
  • 财政年份:
    2021
  • 负责人:
    Hannah Marion Burgess
  • 依托单位:
Cellular RNAs in anti-viral immunity to HSV1
  • 批准号:
    10471808
  • 项目类别:
  • 资助金额:
    $13.5万
  • 财政年份:
    2021
  • 负责人:
    Hannah Marion Burgess
  • 依托单位:
Cellular RNAs in anti-viral immunity to HSV1 - Resubmission - 1
海外基金